Kaiser Permanente-Cadillac is a clinical research site located in Los Angeles, California, United States 90034.
Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.
Kaiser Permanente-Cadillac has participated in 36 clinical trials with 8 currently active.
Therapeutic areas: Myelodysplastic Syndromes (MDS), Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7.
Sponsors: National Heart, Lung, and Blood Institute (NHLBI), SWOG Cancer Research Network, National Cancer Institute (NCI).
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Los Angeles
Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Kaiser Permanente-Cadillac has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Kaiser Permanente-Cadillac has 36 clinical trials on record, with 8 currently active. Their work covers Myelodysplastic Syndromes (MDS), Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7.
Kaiser Permanente-Cadillac has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.